Age Related Macular Degeneration Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2020 - 2025

Report Code: HCR 19073 Report Format: PDF + Excel (Delivery in 48 Hrs)

Overview

Age related Macular Degeneration Market is projected to reach revenue of $12.85 billion by 2025, and is estimated to grow at a CAGR of 7.7% during the forecast period 2019-2025. The Age Related Macular Degeneration market size, in 2018, is said to be $7.65 billion. Age related macular degeneration is a medical condition of the eye which diminishes the eyesight with age. Thus a rising geriatric population will contribute to growth of this market.

Key Takeaways

  • The market is estimated to grow at a CAGR of 7.7% owing to the rising prevalence of AMD along with rise in geriatric population.
  • Companies are adopting various strategic alliances to expand in various regions. Investments in research have increased in order to develop treatment drugs for AMD.
  • Rare case of macular degeneration occur in children, teenagers, or adults, called the Stargardt disease, which is an inherited retinal disorder. 

Product Type - Segment Analysis

AMD is of two types; dry and wet AMD. Dry AMD is caused by the formation of deposits called under the retina; and, wet AMD is caused by abnormal growth of the blood vessels beneath the macula. Wet AMD accounts for larger share in the market owing to rising prevalence of this compared to dry AMD among the geriatric population. This segment also has a growth rate of 7% and is growing faster than the dry AMD segment.

Drug - Segment Analysis

Wet AMD has drugs for its treatment, whereas dry AMD has no available treatment. The drugs used for wet AMD include anti-Vascular Endothelial Growth Factor drugs (anti-VEGF). Commonly used drugs are Lucentis (ranibizumab) and Eylea (aflibercept) that are FDA-approved for the treatment of AMD. Off label drug Avastin (bevacizumab) is also popularly used. Photodynamic therapy (PDT) is also being used as a treatment for wet AMD and it slows the damage to vision.

Route of Administration - Segment Analysis

On the basis of route of administration, the market is segmented into intravenous and intravitreal. The intravitreal segment is said to dominate the market owing as it is more effective due to targeted drug delivery. Also, most anti-VEGF injections are administered using intravitreal or intraocular injections.

Geography - Segment Analysis

In 2018, North America held 43.5% of the global Age Related Macular Degeneration market share. This is owing to the increasing prevalence of AMD as well as the rising number of drug approvals in the country. According to the United States Census Bureau, the older population is estimated to grow significantly in the coming years. As a result, the prevalence of age related macular degeneration is also growing. This will lead to the growth of the market as this region's population will have an increased demand for these treatments.

Drivers – Age Related Macular Degeneration Market

  • Growing geriatric population and prevalence of eye disorders among them

As per World Bank statistics, 8.873% of the global population belong to age category 65 years and above, in 2018. AMD is found to affect patients of the age 60 and above. Thus with rising aging population, the prevalence of AMD will also increase and will contribute to the market growth.

  • Increase in pipeline drugs for AMD

With no actual cure for AMD, pharmaceutical companies are developing various drugs for the treatment. Thus a number of drugs are in the pipeline undergoing development and trials for the treatment of AMD. Anti VEGF therapies are effective in treatment of wet AMD as they drain out the fluid leak and restore vision.

Challenges – Age Related Macular Deg eneration Market

  • Increase in off label drug use due to high cost of on-label drugs

The increasing off-label use of drugs has hindered the growth of the market. Off-label drugs are the use of medicine for disease or medical condition, in a way or dose that has not been approved by the Food and Drug Administration (FDA). In the case of AMD, it is found that the use of Avastin (an off-label drug developed for cancer) is more popular than Lucentis, which costs more.

Age Related Macular Degeneration Industry Outlook

Research & development along with strategic alliances are some of the key strategies adopted by players in the Age Related Macular Degeneration market. Age Related Macular Degeneration top 10 companies are F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceutical Inc., Pfizer Inc., Bayer AG, Ophthotech Corporation, GlaxoSmithKline plc, Neurotech Pharmaceuticals Inc., Alimera Sciences Inc., and StemCells Inc.

Age Related Macular Degeneration Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Age Related Macular Degeneration Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. 

1. Age Related Macular Degeneration Market - Overview
        1.1 Definitions and Scope
2. Age Related Macular Degeneration Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Age Related Macular Degeneration Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Age Related Macular Degeneration Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Age Related Macular Degeneration Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Age Related Macular Degeneration Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Age Related Macular Degeneration Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Age Related Macular Degeneration Market - By Product Type (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
            8.3.1 Wet Amd
            8.3.2 Dry Amd
9. Age Related Macular Degeneration Market - By Drug (Market Size -$Million / $Billion)
        9.1 Lucentis
        9.2 Eylea
        9.3 Avastin
10. Age Related Macular Degeneration - By Route Of Administration (Market Size -$Million / $Billion)
        10.1 Intraveous
        10.2 Intravitreal
11. Age Related Macular Degeneration- By Geography (Market Size -$Million / $Billion)
        11.1 Age Related Macular Degeneration Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Age Related Macular Degeneration- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Age Related Macular Degeneration- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Age Related Macular Degeneration - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong Kong
                  11.8.5.9 Rest of APAC
        11.9 Age Related Macular Degeneration - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Age Related Macular Degeneration Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Age Related Macular Degeneration Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Age Related Macular Degeneration Market - Key Company List by Country Premium
15. Age Related Macular Degeneration Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 F. Hoffmann-La Roche
        15.3 Novartis Ag
        15.4 Pfizer Inc.
        15.5 Regeneron Pharmaceutical
        15.6 Valeant Pharmaceutical International, Inc
        15.7 Company 6
        15.8 Company 7 & More
*Financials would be provided on a best efforts basis for private companies
16. Age Related Macular Degeneration Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Age Related Macular Degeneration Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Age Related Macular Degeneration Market, By Product Type Market 2019-2024 ($M)
1.1 Wet Amd Market 2019-2024 ($M) - Global Industry Research
1.2 Dry Amd Market 2019-2024 ($M) - Global Industry Research
2.Global Age Related Macular Degeneration Market, By Drug Market 2019-2024 ($M)
2.1 Lucentis Market 2019-2024 ($M) - Global Industry Research
2.2 Eylea Market 2019-2024 ($M) - Global Industry Research
2.3 Avastin Market 2019-2024 ($M) - Global Industry Research
3.Global Age Related Macular Degeneration Market, By Route Of Administration Market 2019-2024 ($M)
3.1 Intraveous Market 2019-2024 ($M) - Global Industry Research
3.2 Intravitreal Market 2019-2024 ($M) - Global Industry Research
4.Global Age Related Macular Degeneration Market, By Product Type Market 2019-2024 (Volume/Units)
4.1 Wet Amd Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Dry Amd Market 2019-2024 (Volume/Units) - Global Industry Research
5.Global Age Related Macular Degeneration Market, By Drug Market 2019-2024 (Volume/Units)
5.1 Lucentis Market 2019-2024 (Volume/Units) - Global Industry Research
5.2 Eylea Market 2019-2024 (Volume/Units) - Global Industry Research
5.3 Avastin Market 2019-2024 (Volume/Units) - Global Industry Research
6.Global Age Related Macular Degeneration Market, By Route Of Administration Market 2019-2024 (Volume/Units)
6.1 Intraveous Market 2019-2024 (Volume/Units) - Global Industry Research
6.2 Intravitreal Market 2019-2024 (Volume/Units) - Global Industry Research
7.North America Age Related Macular Degeneration Market, By Product Type Market 2019-2024 ($M)
7.1 Wet Amd Market 2019-2024 ($M) - Regional Industry Research
7.2 Dry Amd Market 2019-2024 ($M) - Regional Industry Research
8.North America Age Related Macular Degeneration Market, By Drug Market 2019-2024 ($M)
8.1 Lucentis Market 2019-2024 ($M) - Regional Industry Research
8.2 Eylea Market 2019-2024 ($M) - Regional Industry Research
8.3 Avastin Market 2019-2024 ($M) - Regional Industry Research
9.North America Age Related Macular Degeneration Market, By Route Of Administration Market 2019-2024 ($M)
9.1 Intraveous Market 2019-2024 ($M) - Regional Industry Research
9.2 Intravitreal Market 2019-2024 ($M) - Regional Industry Research
10.South America Age Related Macular Degeneration Market, By Product Type Market 2019-2024 ($M)
10.1 Wet Amd Market 2019-2024 ($M) - Regional Industry Research
10.2 Dry Amd Market 2019-2024 ($M) - Regional Industry Research
11.South America Age Related Macular Degeneration Market, By Drug Market 2019-2024 ($M)
11.1 Lucentis Market 2019-2024 ($M) - Regional Industry Research
11.2 Eylea Market 2019-2024 ($M) - Regional Industry Research
11.3 Avastin Market 2019-2024 ($M) - Regional Industry Research
12.South America Age Related Macular Degeneration Market, By Route Of Administration Market 2019-2024 ($M)
12.1 Intraveous Market 2019-2024 ($M) - Regional Industry Research
12.2 Intravitreal Market 2019-2024 ($M) - Regional Industry Research
13.Europe Age Related Macular Degeneration Market, By Product Type Market 2019-2024 ($M)
13.1 Wet Amd Market 2019-2024 ($M) - Regional Industry Research
13.2 Dry Amd Market 2019-2024 ($M) - Regional Industry Research
14.Europe Age Related Macular Degeneration Market, By Drug Market 2019-2024 ($M)
14.1 Lucentis Market 2019-2024 ($M) - Regional Industry Research
14.2 Eylea Market 2019-2024 ($M) - Regional Industry Research
14.3 Avastin Market 2019-2024 ($M) - Regional Industry Research
15.Europe Age Related Macular Degeneration Market, By Route Of Administration Market 2019-2024 ($M)
15.1 Intraveous Market 2019-2024 ($M) - Regional Industry Research
15.2 Intravitreal Market 2019-2024 ($M) - Regional Industry Research
16.APAC Age Related Macular Degeneration Market, By Product Type Market 2019-2024 ($M)
16.1 Wet Amd Market 2019-2024 ($M) - Regional Industry Research
16.2 Dry Amd Market 2019-2024 ($M) - Regional Industry Research
17.APAC Age Related Macular Degeneration Market, By Drug Market 2019-2024 ($M)
17.1 Lucentis Market 2019-2024 ($M) - Regional Industry Research
17.2 Eylea Market 2019-2024 ($M) - Regional Industry Research
17.3 Avastin Market 2019-2024 ($M) - Regional Industry Research
18.APAC Age Related Macular Degeneration Market, By Route Of Administration Market 2019-2024 ($M)
18.1 Intraveous Market 2019-2024 ($M) - Regional Industry Research
18.2 Intravitreal Market 2019-2024 ($M) - Regional Industry Research
19.MENA Age Related Macular Degeneration Market, By Product Type Market 2019-2024 ($M)
19.1 Wet Amd Market 2019-2024 ($M) - Regional Industry Research
19.2 Dry Amd Market 2019-2024 ($M) - Regional Industry Research
20.MENA Age Related Macular Degeneration Market, By Drug Market 2019-2024 ($M)
20.1 Lucentis Market 2019-2024 ($M) - Regional Industry Research
20.2 Eylea Market 2019-2024 ($M) - Regional Industry Research
20.3 Avastin Market 2019-2024 ($M) - Regional Industry Research
21.MENA Age Related Macular Degeneration Market, By Route Of Administration Market 2019-2024 ($M)
21.1 Intraveous Market 2019-2024 ($M) - Regional Industry Research
21.2 Intravitreal Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
2.Canada Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
3.Mexico Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
4.Brazil Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
5.Argentina Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
6.Peru Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
7.Colombia Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
8.Chile Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
9.Rest of South America Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
10.UK Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
11.Germany Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
12.France Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
13.Italy Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
14.Spain Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
15.Rest of Europe Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
16.China Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
17.India Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
18.Japan Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
19.South Korea Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
20.South Africa Age Related Macular Degeneration Market Revenue, 2019-2024 ($M)
21.North America Age Related Macular Degeneration By Application
22.South America Age Related Macular Degeneration By Application
23.Europe Age Related Macular Degeneration By Application
24.APAC Age Related Macular Degeneration By Application
25.MENA Age Related Macular Degeneration By Application
26.F. Hoffmann-La Roche, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Regeneron Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Valeant Pharmaceutical International, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Pfizer Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)